In a retrospective study involving 37 patients with CHL, pre-treatment serum levels of VEGF, fibroblast growth factor-2 (FGF-2), hepatocyte growth factor (HGF) were measured and compared to post-therapy levels. Here, HGF is linked to classic Hodgkin lymphoma.